Clinical Trial Update: Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and tolerability of DM199 in acute ischemic stroke completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DM199

Snippet

Sponsor: DiaMedica Therapeutics Inc | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED